Molecular Pathology Laboratory Network

CEA

Colorectal, lung, breast, ovary, uterus

Chemiluminescent Immunoassay
CEA is performed by Ascendant Medical Laboratory

82378 - Carcinoembryonic antigen (CEA)

< 24 hours

7.0 mL, gold or red SST vacutainer

Specimen not stored at correct temperatures; Specimen exceeds stability time

See report

Tumor markers
CellSearch for breast, colon and prostate cancer

This test measures the amount of protein that may be found in the blood of some individuals who have certain kinds of cancer. It is most often associated with colon or rectal cancers, but can be present for pancreas, breast, ovary or lung.

The test can be performed to determine how far the cancer has spread, to check the success of treatment and to see if the cancer cells have returned after treatment.

1. Kawachi Riken et al. (2009). Clinical significance of preoperative carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: can preoperative carcinoembryonic antigen level predict pathological stage? Interactive CardioVascular and Thoracic Surgery. 9:199.
2. Duffy MJ. (2001). Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem. Apr;47(4):624-30.